The metabolic landscape of urological cancers: New therapeutic perspectives

Cancer Letters
Vera Miranda-GonçalvesCarmen Jerónimo

Abstract

Deregulation of cell metabolism is an established cancer hallmark that contributes to tumor initiation and progression, as well as tumor heterogeneity. In solid tumors, alterations in different metabolic pathways, including glycolysis, pentose phosphate pathway, glutaminolysis and fatty acid metabolism, support the high proliferative rates and macromolecule biosynthesis of cancer cells. Despite advances in therapy, urothelial tumors still exhibit high recurrence and mortality rates, especially in advanced stages of disease. These tumors harbor gene mutations and expression patterns which play an important role in metabolic reprogramming. Taking into account the unique metabolic features underlying carcinogenesis in these cancers, new and promising therapeutic targets based on metabolic alterations must be considered. Furthermore, the combination of metabolic inhibitors with conventional targeted therapies may improve effectiveness of treatments. This review will summarize the metabolic alterations present in urological tumors and the results with metabolic inhibitors currently available.

References

Mar 16, 2002·Journal of Applied Physiology·Grant B McClelland, George A Brooks
Feb 24, 1956·Science·O WARBURG
Nov 8, 2003·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·J TurynJ Swierczynski
Jan 8, 2004·Annals of Medicine·Patrick J PollardIan P M Tomlinson
Apr 15, 2004·Endocrine Reviews·Cynthia A Heinlein, Chawnshang Chang
Nov 2, 2004·Nature Reviews. Cancer·Robert A Gatenby, Robert J Gillies
Jan 8, 2008·Cell Metabolism·Ralph J DeBerardinisCraig B Thompson
Feb 28, 2008·International Journal of Cancer. Journal International Du Cancer·Sigrun LangbeinJohannes F Coy
Jun 17, 2008·The Journal of Urology·Akio HoriguchiMasamichi Hayakawa
Nov 27, 2008·Proceedings of the National Academy of Sciences of the United States of America·David R WiseCraig B Thompson
Jan 15, 2009·Nature Reviews. Cancer·Nicholas C Denko
Jul 30, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Karen E Knudsen, Howard I Scher
Dec 18, 2009·Journal of Cellular and Molecular Medicine·Johanna ChicheJacques Pouysségur
Jan 1, 2010·Mayo Clinic Proceedings·Manish Kohli, Donald J Tindall
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Anne LeChi V Dang
Apr 9, 2010·Future Oncology·Richard FlavinMassimo Loda
Jul 16, 2010·Developmental Cell·Mikala EgebladZena Werb
Nov 16, 2010·Current Opinion in Genetics & Development·M Christiane Brahimi-HornJacques Pouysségur
Feb 2, 2011·Molecular Cancer Therapeutics·Nancy B KuemmerleWilliam B Kinlaw
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Mar 15, 2011·Urologic Oncology·Seok Joong YunWun-Jae Kim
May 18, 2011·Oncology·Irène AsmaneJean-Emmanuel Kurtz
Aug 5, 2011·Science Translational Medicine·Denise A ChanAmato J Giaccia
Aug 16, 2011·Clinical & Experimental Metastasis·Joseph L SottnikDouglas H Thamm
Sep 10, 2011·Frontiers in Pharmacology·Paolo E PorporatoPierre Sonveaux
Nov 16, 2011·Cancer Research·Franziska HirschhaeuserWolfgang Mueller-Klieser
Feb 22, 2012·Seminars in Cell & Developmental Biology·Dania Daye, Kathryn E Wellen
Jan 10, 2013·Current Cancer Drug Targets·Faton Agani, Bing-Hua Jiang
Mar 20, 2013·Molecular Aspects of Medicine·M-C FranzG Kovacs
Apr 9, 2013·Biochimica Et Biophysica Acta·Giorgia ZadraMassimo Loda

❮ Previous
Next ❯

Citations

Aug 14, 2020·International Journal of Molecular Sciences·Jiapeng Chen, Hongbing Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.